Clinical Roundup Camizestrant combination delayed time to first progression by 55% in patients with advanced HR+ breast cancer with ESR1 tumor mutation June 05, 2026Vol.52 No.22
Clinical Roundup OST-HER2 achieves 2.5-year OS in fully resected pulmonary metastatic osteosarcoma, phase IIb trial finds June 05, 2026Vol.52 No.22
Clinical Roundup Catheter with specialized nanosensors could enable earlier detection of bladder cancer, MIT study finds June 05, 2026Vol.52 No.22
Clinical Roundup Teclistamab extends OS, deepens remissions in landmark trial published in NEJM and presented at ASCO May 29, 2026Vol.52 No.21
Clinical Roundup Dermatologists and oncologists call for overhaul of widely used cancer side-effect grading system May 29, 2026Vol.52 No.21
Clinical Roundup Adding a lower cutoff value for CA19-9 may identify additional high-risk cases of pancreatic cancer May 29, 2026Vol.52 No.21
Clinical Roundup Ovarian cancer cells use stress hormone signaling to shut down immune system, UTSW study finds May 29, 2026Vol.52 No.21
Clinical Roundup Human cells can exchange genomic DNA that alter cell behavior, UT Southwestern-led study finds May 29, 2026Vol.52 No.21
Clinical Roundup AI model links tumor mutations to treatment response, UCSD study finds May 29, 2026Vol.52 No.21
